Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT06367959 Recruiting - Cancer Clinical Trials

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

Start date: July 27, 2023
Phase: N/A
Study type: Interventional

To learn more about participant experience as a Chinese immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

NCT ID: NCT06361862 Recruiting - Cancer Clinical Trials

Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

This aim of this study is to investigate whether active alerts during CVSM result in an increased number of diagnostic tests and treatments in complication free patients, hypothesizing that more interventions are performed in the CVSM-group than standard of care (EWS) group.

NCT ID: NCT06360471 Recruiting - Cancer Clinical Trials

Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer

Start date: October 1, 2023
Study type: Observational [Patient Registry]

To explore whether there is a significant difference in the cumulative live birth rate and maternal and child health outcomes between cancer patients who undergo or do not undergo fertility preservation before receiving anti-tumor treatment and non-cancer patients who undergo assisted reproductive technology treatment/natural pregnancy. This study will be conducted in the Clinical Center of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University. 2800 women diagnosed with malignant cancers who has desire to reproduce will be enrolled in this study. Statistical analysis of the data will be performed.

NCT ID: NCT06357000 Completed - Clinical trials for Coronary Artery Disease

Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes

Start date: January 1, 2008
Study type: Observational

To evaluate the association between time from PCI to cancer surgery and cardiovascular and oncologic outcomes in early-stage cancer patients, A retrospective, population-based cohort study was conducted using data from the Korean National Health Insurance Service (K-NHIS) database.

NCT ID: NCT06356363 Not yet recruiting - Cancer Clinical Trials

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

Start date: June 1, 2024
Study type: Observational

Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.

NCT ID: NCT06355245 Recruiting - Cancer Clinical Trials

MEDECA - Markers in Early Detection of Cancer

Start date: March 1, 2018
Study type: Observational

Early diagnosis of cancer is key for improving patient outcomes, but cancers are difficult to diagnose if patients present with unspecific symptoms. The principal objective of the MEDECA (Markers in Early Detection of Cancer) study is to identify a multi-analyte blood test that can detect and map occult cancer within a mixed population of patients presenting with serious but unspecific symptoms. The study will include 1500 patients referred to the Diagnostic Center at Danderyd Hospital (DC DS), a multidisciplinary diagnostic center referral pathway for patients with radiological findings suggestive of metastasis without known primary tumor or suspicion of serious but unspecific symptoms. Blood samples are collected prior to a standardized and extensive cancer diagnostic work-up, including an expanded panel of biochemical analyses and extensive imaging such as computed tomography or magnetic resonance investigations. In collaboration with world-leading international scientists, the blood samples will be analyzed for a panel of novel and established blood biomarkers predictive of an underlying cancer, including markers of neutrophil extracellular traps, circulating tumor DNA, platelet mRNA profiling, affinity-based proteomics and nuclear magnetic resonance metabolomics. The diagnostic accuracy of the blood biomarkers with respect to cancer detection during the diagnostic work-up will be analyzed through machine learning.

NCT ID: NCT06353178 Recruiting - Cancer Clinical Trials

Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers

Start date: April 8, 2024
Phase: N/A
Study type: Interventional

Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.

NCT ID: NCT06350214 Completed - Cancer Clinical Trials

Physical Activity and Nutrition in Cancer Survivors

Start date: January 1, 2007
Study type: Observational

This study aims to investigate the independent and combined associations between physical activity and nutrition condition with mortality among cancer survivors.

NCT ID: NCT06345924 Recruiting - Cancer Clinical Trials

Music Therapy for Cancer Patients(Meraki_PC)

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The overall aim of the study is to analyse the impact of a music therapy-based treatment on the emotional well-being and quality of life of cancer patients in palliative care (PC). To this end, the effectiveness and efficiency of a music therapy-based treatment to improve adaptation to illness and psychological well-being in this population will be validated and implemented. Specifically, the implementation of an individualised treatment programme for palliative care patients will be carried out.

NCT ID: NCT06340906 Not yet recruiting - Cancer Clinical Trials

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Start date: May 15, 2024
Phase: N/A
Study type: Interventional

The investigators are conducting this research study is to evaluate the feasibility (recruitment, compliance, safety, and acceptance) of using electroacupuncture (EA) to manage complex symptoms such as pain, nausea/vomiting, diarrhea, and insomnia in patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Additionally, the investigators are aiming to determine the effectiveness of EA in reducing these symptoms, and to examine how EA impacts important biomarkers, or proteins in the blood, that can be used as indicators or signs of these symptoms.